Miro, Roselle .

HRN: 13-96-54  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2026
METRONIDAZOLE 500MG (TAB)
07/03/2026
07/10/2026
PO
500
Tid
Thickly Msaf
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: